• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number PAJR072502E
Device Problems Separation Failure (2547); Difficult or Delayed Activation (2577)
Patient Problems Thrombus (2101); No Consequences Or Impact To Patient (2199); Device Embedded In Tissue or Plaque (3165)
Event Date 07/16/2019
Event Type  malfunction  
Event Description
The patient presented with a distal edge stenosis of a gore® viabahn® endoprosthesis which was previously implanted in the right superficial femoral artery.The stenosis was treated with a bare metal stent (innova).It was planned to additionally implant a gore® viabahn® endoprosthesis with propaten bioactive surface within the previously implanted viabahn® endoprosthesis.It was reported that when the viabahn® endoprosthesis was deployed, it moved slightly forward in distal direction and it only expanded halfway, then the deployment line has broken.Then the physician opened the catheter proximally to reach the remaining deployment line.When pulling the remaining deployment line it broke again.It was stated that it was not necessary to use excessive force when pulling the deployment line to deploy the device.The deployment line ruptured pretty easily.The physician decided to make a distal approach via a pedal access.He advanced a balloon from distal direction to the halfway expanded viabahn® endoprosthesis and dilated the constrained part step by step.Eventually the viabahn® endoprosthesis was fully expanded and the delivery catheter could be removed from the patient.Reportedly the physician couldn't say for sure or rule it out whether a part of the deployment line remained in the patient.During the procedure a thrombus has come loose proximal which would require a reintervention.Due to lack of resources the reintervention was postponed.Reportedly the patient is doing well.
 
Manufacturer Narrative
D10: the endoprosthesis remains in the patient.Delivery catheter, deployment knob and deployment line were returned for investigation.H6: code-213: the following observations were made: the delivery catheter, deployment knob, and deployment line were returned.There was approximately 207 cm of deployment line with two single fibers at the end measuring 15 cm and 13 cm.The delivery catheter was returned in two pieces.The first piece measured approximately 5.5 cm from the hub and the second piece measured approximately 120 cm and included the distal tip.The second piece was cut in half for approximately 57 cm and a fiber was protruding from the cut delivery catheter.The distal shaft, upon which the endoprosthesis was mounted, was kinked at the transition.The remainder of the device was unremarkable.Based on the device examination performed, no manufacturing anomalies were identified to which the event could be definitively attributed.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8887029
MDR Text Key154305287
Report Number2017233-2019-00623
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 09/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/13/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/25/2021
Device Catalogue NumberPAJR072502E
Device Lot Number20262569
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/21/2019
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age61 YR
-
-